Ramius backs sale of Datascope's patient monitoring business

By Lisa Kerner

Charlotte, N.C., March 18 - Datascope Corp. investors led by Ramius LLC said they support the sale of the company's patient monitoring business to Mindray Medical International, Ltd. for $240 million.

Datascope announced the sale in a March 11 news release.

The investors believe the proposed transaction benefits the patient monitoring business and is in the best interest of Datascope shareholders, according to a schedule 13D filing with the Securities and Exchange Commission.

Ramius also supports Datascope's plan to return the proceeds to shareholders through a share repurchase, special dividends, or a combination of both.

The investors beneficially own 1,041,676 shares, or 6.7%, of the Montvale, N.J., medical device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.